SC
Sopris Capital Associates
Venture CapitalActiveSopris Capital Associates, a U.S.-based investment firm, offers growth capital to healthcare and technology-enabled B2B service businesses.
31
Investments
6
Exits
null
AUM
19.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sopris Capital Associates.
Investment Thesis & Strategy
Sopris Capital Associates invests growth capital in healthcare and technology-enabled B2B service businesses, targeting companies with strong growth potential.
Investment Activity
Deals per year over the last 6 years
1
20180
20192
20206
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 31 companies
P
PaceMate
Healthcare · Growth, 2023
C
CareRev
Healthcare · Growth, 2022
J
Jasper Health
Healthcare · Growth, 2022
V
Vytalize Health
Healthcare · Growth, 2021
C
CareBridge
Healthcare · Growth, 2021
H
Healthify
Healthcare · Growth, 2021
W
Wellframe
Healthcare · Growth, 2021
C
Casetext
Enterprise · Growth, 2021
V
Venafi
Enterprise · Growth, 2021
M
Medly Pharmacy
Healthcare · Growth, 2020
V
Vesta Healthcare
Healthcare · Growth, 2020
P
PatientPop
Healthcare · Growth, 2018
Notable Exits
CompanyTypeYearValue / Acquirer
Health CatalystIPO2019—
BioScripAcquisition2019—
Vascular TherapiesAcquisition2018—
MedDataAcquisition2017—
HealthPortAcquisition2016—
PharmaNetAcquisition2010—
Frequently Asked Questions
Sopris Capital Associates focuses on Series A, Series B, Series C+ stage investments.